Vax Patent Decision Still Pending

The wealthy vs. developing countries scuffle over patent rights to COVID-19 vaccines has intensified at the World Trade Organization this week.

South Africa and India are leading a bloc of mostly developing countries pushing to waive WTO intellectual property agreements to allow more manufacturers to make big-name vaccine formulas. 
 
But: Rich Western countries like the US and the UK—home to pharma giants—oppose the move.

WTO Director-General Ngozi Okonjo-Iweala urged countries to act fast on this “vitally important” decision that could ramp up production in emerging markets.


Reuters

Rich Countries Could Donate Surplus Doses

Over the next 1-2 years, rich countries may have enough surplus doses to immunize everyone in poorer nations lacking vaccines.

Last year, dozens of rich countries hedged their bets and pre-purchased vaccine candidates in development. Now, most of those have been proven efficacious, setting the stage for massive surpluses. 
 
The extra vaccines could be a major boost but getting them into arms could mean a lengthy process fraught with regulatory, logistical, and liability hurdles.

Smart Move: Donate the vaccine before it leaves the factory, says Gian Gandhi, COVAX coordinator at UNICEF: “We get into problems if it’s a dose that’s sitting in a central storage facility in Berlin or Paris or London.”

Science

Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top